Kolkata, September 20, 2026 : Kolkata’s infectious-disease landscape is changing with the seasons, bringing different health challenges into focus at the same time. In recent months, the city has seen a mix of respiratory infections, including influenza, H1N1 and COVID-19, while the monsoon has also brought dengue into sharper focus. This presents an important lesson; when several infections can produce similar symptoms, identifying the actual cause of illness becomes critical.
Recent reports from Kolkata have highlighted the circulation of influenza A and B, H1N1, COVID-19 and other respiratory viruses. In one recent episode, students fell ill and six subsequently tested positive for influenza. Such clusters demonstrate how quickly respiratory infections can become a concern beyond individual patients.
At the same time, dengue surveillance is becoming increasingly important as the monsoon progresses. West Bengal has reported more than 4,000 dengue cases so far this year, although this remains lower than the corresponding figure last year. Importantly, health authorities have cautioned against complacency because August and September are typically periods of greater dengue activity. In Kolkata, cases have so far been reported from 12 municipal wards, while 61 wards have reported no cases.
These developments highlight a fundamental diagnostic challenge. Fever, fatigue, body ache and weakness do not point to a single disease. Respiratory symptoms may suggest influenza or COVID-19, while fever and body ache during the monsoon may also warrant consideration of dengue and other infections. Symptoms are an important starting point, but they do not always provide the complete answer. This is where microbiological diagnosis becomes important.
Modern diagnostic tools allow clinicians to move from a broad clinical suspicion towards identifying the pathogen responsible. For respiratory infections, molecular methods such as real-time RT-PCR can detect viral genetic material and, where appropriate, help identify or subtype pathogens. Modern molecular diagnostics, including real-time RT-PCR and multiplex testing, are helping clinicians identify specific respiratory pathogens more accurately, particularly when infections such as influenza, H1N1, COVID-19 and other respiratory viruses present with overlapping symptoms.
Another important development is the growing role of nucleic acid amplification testing (NAAT). NAAT is a broader category of molecular tests that detect the genetic material of a pathogen; RT-PCR is one commonly used form of NAAT. For infections such as dengue, molecular testing can be particularly useful during the early phase of illness. A positive dengue NAAT, including RT-PCR, can provide evidence of current infection, while testing strategies can also incorporate antigen and antibody-based methods depending on the stage of illness.
The value of these technologies is not simply that they are modern. Their real value lies in helping reduce diagnostic uncertainty. Accurate identification can support more informed treatment decisions, help determine when antiviral therapy may be appropriate, reduce unnecessary antibiotic use where a viral cause has been established, and assist with infection-control measures. It can also help doctors distinguish between illnesses that may initially appear clinically similar but require very different approaches.
However, the importance of diagnosis is not limited to treatment decisions alone. In many cases, treatment may continue to depend on the patient’s symptoms, severity and overall clinical condition. Diagnostic results also contribute to epidemiological surveillance by showing which pathogens and strains are circulating in the community. This is particularly important for influenza, as information on circulating strains helps health authorities assess which strains should be considered for inclusion in future seasonal influenza vaccines.
The importance extends beyond the individual patient. Laboratory results, when appropriately aggregated and interpreted, can provide valuable information about what pathogens are circulating in a community. This can help identify clusters, monitor changing patterns and strengthen public-health preparedness.
For Kolkata, this is particularly relevant because the city’s disease burden is not defined by one pathogen or one season. Respiratory viruses may dominate one period, while vector-borne diseases such as dengue become more prominent as the monsoon progresses. The Kolkata Municipal Corporation itself places dengue and malaria alongside respiratory infections and TB within its communicable-disease control framework, underscoring the breadth of the city’s infectious-disease challenge.
The way forward, therefore, is not simply to test more, but to test appropriately, at the right time, and with reliable methods. Clinical assessment remains fundamental, but when symptoms overlap or disease patterns change, microbiological confirmation can provide an additional layer of certainty.
For a city like Kolkata, accurate diagnosis is ultimately about more than obtaining a laboratory result. It is about understanding what is causing illness, choosing the most appropriate response, protecting patients and communities, and ensuring that emerging disease patterns are recognized early.
As Kolkata navigates a changing infectious-disease landscape, the ability to move from symptoms to pathogen-level evidence will become increasingly important, not only for individual patient care, but for the city’s broader public-health response.
